8-K: Sabra Health Care REIT Launches New $750M ATM Program

Sabra Health Care REIT, Inc. has established a new At-The-Market equity offering program for up to $750 million, replacing its prior $500 million program.

Summary

• Sabra Health Care REIT, Inc. (the "Company") entered into a new Equity Distribution Agreement on August 5, 2025, establishing an At-The-Market (ATM) program.
• The new ATM program allows for the issuance and sale of common stock with an aggregate gross offering price of up to $750.0 million.
• Sales can be made through agents acting as sales agents or directly to agents acting as principals, including at-the-market offerings on Nasdaq or privately negotiated transactions.
• The Company may also enter into forward sale agreements, with proceeds from physical settlement expected within one year.
• Aggregate compensation to agents for sales of Issuance Shares will be up to $11.25 million.
• Forward Purchasers will receive commissions not exceeding 1.5% of the volume-weighted average price for Forward Shares.
• The Company terminated its previous $500.0 million ATM program, under which $109.3 million of common stock remained unsold.
• Outstanding forward sale agreements totaling $266.5 million from the prior program will remain in effect and have a one-year settlement term.
• Net proceeds from the new program are intended for repaying indebtedness, funding future investments, and/or general corporate purposes.

Sentiment

Score: 7

Explanation: The filing indicates a proactive approach to capital management, securing a larger and more flexible financing tool. While potential dilution exists, the stated uses of proceeds for debt repayment and future investments are generally positive for long-term stability and growth. The termination of the prior program with unsold shares is a minor negative, but the new program's increased capacity outweighs it.

Positives

• The new ATM program provides significant financial flexibility, increasing the potential capital raise capacity to $750.0 million from the previous $500.0 million.
• The ability to use proceeds for debt repayment, future investments, and general corporate purposes offers strategic optionality for the Company's growth and financial health.
• The inclusion of forward sale agreements provides additional flexibility in managing capital structure and timing of share issuance.

Negatives

• The termination of the prior ATM program left $109.3 million in unsold common stock, indicating that the previous program was not fully utilized.
• A substantial amount of common stock ($266.5 million) from the prior program remains subject to outstanding forward sale agreements, which could still lead to future dilution upon settlement.

Risks

• Market conditions may prevent agents from successfully selling shares or forward purchasers from borrowing and delivering shares for sale.
• Stock loan costs for forward sales could exceed the specified maximum rate, potentially impacting the economics of such transactions.
• Regulatory disruptions or changes in law/SEC policy could affect the ability to conduct sales or return shares to lenders.
• The Company's possession of material non-public information would require suspension of sales under the program.
• Potential for dilution of existing shareholders' equity due to the issuance of new common stock.
• Non-compliance with various laws and regulations (e.g., environmental, anti-corruption, money laundering, REIT status) could result in a Material Adverse Change.
• Breach of ownership restrictions (e.g., Section 13, Exchange, Charter, Regulatory) could limit share delivery or trigger termination events.
• Insolvency of the Company would lead to immediate termination of the transaction obligations.

Future Outlook

The Company intends to use the net proceeds from the new ATM program to repay indebtedness, fund possible future investments, and/or for general corporate purposes. Any forward sale agreements entered into are expected to be physically settled by delivery of common stock within one year, though cash or net share settlement options are available.

Industry Context

At-The-Market (ATM) equity programs are a common and flexible financing tool for Real Estate Investment Trusts (REITs), including healthcare REITs like Sabra. They allow companies to raise capital opportunistically over time, minimizing market impact compared to large, single-block offerings. This new, larger program positions Sabra to enhance its liquidity and fund strategic initiatives in a dynamic healthcare real estate market, which is often influenced by demographic shifts and healthcare policy changes.

Comparison to Industry Standards

• The establishment of an ATM program is a standard capital-raising practice for publicly traded REITs, providing flexibility to issue shares directly into the market at prevailing prices.
• The maximum aggregate offering price of $750.0 million is a substantial amount, comparable to the scale of capital raises undertaken by other large-cap REITs to support portfolio growth or debt management.
• The use of both direct sales through agents and forward sale agreements aligns with common industry practices, allowing for immediate capital access or deferred settlement based on market conditions and company needs.
• The commission rates for agents and forward purchasers (up to 1.5%) are within the typical range for ATM programs in the financial services industry, reflecting standard compensation for such services.

Stakeholder Impact

• Shareholders: Potential for dilution due to the issuance of new common stock, but also potential for increased value if capital is effectively deployed for growth and debt reduction.
• Creditors: Positive impact as proceeds may be used to repay indebtedness, potentially improving the Company's credit profile.
• Employees & Customers: Indirect positive impact through enhanced financial stability and potential for business expansion and new investments.

Next Steps

• The Company will proceed with the issuance and sale of common stock under the new $750.0 million ATM program.
• The Company may enter into one or more forward sale agreements under the new program.
• The Company will use net proceeds to repay indebtedness, fund future investments, and/or for general corporate purposes.
• Outstanding forward sale agreements from the prior program will be settled over their one-year term.

Key Dates

Recommendation

The filing details a standard capital-raising mechanism for a REIT, providing financial flexibility for debt management and future investments. While the potential for share dilution exists, it's a common and often necessary step for growth-oriented companies. Without specific details on the immediate deployment of funds or current operational performance, the news is largely neutral to slightly positive, suggesting a 'hold' stance for seasoned investors who would monitor the execution of the capital deployment strategy.

Keywords

REIT, Healthcare REIT, Equity Distribution Agreement, ATM Program, At-The-Market Offering, Common Stock, Capital Raise, SEC Filing, Form 8-K, Forward Sale Agreement, Debt Repayment, Investments, Corporate Finance